Literature DB >> 17114849

Respiratory-chain enzyme activities in isolated mitochondria of lymphocytes from patients with Parkinson's disease: preliminary study.

Santosh Shinde1, K Pasupathy.   

Abstract

BACKGROUND: Evidence suggests that mitochondrial dysfunction stimulates the production of reactive oxygen species (ROS) that promote neural cell death in stroke and in Parkinson's disease. The sites of mitochondrial ROS production are not established but are generally believed to be located within the electron transport chain. AIMS: We studied the mitochondrial respiratory chain enzymes function from human circulating lymphocytes. SETTING AND
DESIGN: Open study.
MATERIALS AND METHODS: Forty patients with Parkinson's disease (PD) with 30 age-matched control subjects were selected in this study. The patients had received no treatment before the study was conducted. STATISTICAL ANALYSIS: The data from patients and controls were compared using two-tailed student's t-test and values were expressed as means +/- standard deviation (SD).
RESULTS: Respiratory complex I + III and IV activities were significantly lower (P < 0.001) in patients than in control subjects.
CONCLUSIONS: The use of lymphocytes for investigating the respiratory chain enzymes provides an easy, noninvasive method to assess mitochondrial function in patients with PD. Furthermore, our study supports the hypothesis that a biochemical defect in the respiratory chain may be involved in the pathogenesis of PD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17114849     DOI: 10.4103/0028-3886.28112

Source DB:  PubMed          Journal:  Neurol India        ISSN: 0028-3886            Impact factor:   2.117


  17 in total

Review 1.  Mitochondrial dysfunction in the limelight of Parkinson's disease pathogenesis.

Authors:  Rebecca Banerjee; Anatoly A Starkov; M Flint Beal; Bobby Thomas
Journal:  Biochim Biophys Acta       Date:  2008-11-14

Review 2.  Multivariate meta-analyses of mitochondrial complex I and IV in major depressive disorder, bipolar disorder, schizophrenia, Alzheimer disease, and Parkinson disease.

Authors:  L Holper; D Ben-Shachar; J J Mann
Journal:  Neuropsychopharmacology       Date:  2018-05-16       Impact factor: 7.853

3.  LC/MS characterization of rotenone induced cardiolipin oxidation in human lymphocytes: implications for mitochondrial dysfunction associated with Parkinson's disease.

Authors:  Yulia Y Tyurina; Daniel E Winnica; Valentina I Kapralova; Alexandr A Kapralov; Vladimir A Tyurin; Valerian E Kagan
Journal:  Mol Nutr Food Res       Date:  2013-05-03       Impact factor: 5.914

4.  G1/S Cell Cycle Checkpoint Dysfunction in Lymphoblasts from Sporadic Parkinson's Disease Patients.

Authors:  Noemí Esteras; Carolina Alquézar; Fernando Bartolomé; Ana de la Encarnación; Félix Bermejo-Pareja; José Antonio Molina; Ángeles Martín-Requero
Journal:  Mol Neurobiol       Date:  2014-09-03       Impact factor: 5.590

5.  Efflux of iron from the cerebrospinal fluid to the blood at the blood-CSF barrier: effect of manganese exposure.

Authors:  Xueqian Wang; G Jane Li; Wei Zheng
Journal:  Exp Biol Med (Maywood)       Date:  2008-10-10

6.  Oxidative stress in skin fibroblasts cultures from patients with Parkinson's disease.

Authors:  Pilar del Hoyo; Alberto García-Redondo; Fernando de Bustos; José Antonio Molina; Youssef Sayed; Hortensia Alonso-Navarro; Luis Caballero; Joaquín Arenas; José A G Agúndez; Félix Javier Jiménez-Jiménez
Journal:  BMC Neurol       Date:  2010-10-19       Impact factor: 2.474

7.  Mitochondrial dysfunction in Parkinson's disease.

Authors:  P C Keane; M Kurzawa; P G Blain; C M Morris
Journal:  Parkinsons Dis       Date:  2011-03-15

Review 8.  The bad, the good, and the ugly about oxidative stress.

Authors:  Marlene Jimenez-Del-Rio; Carlos Velez-Pardo
Journal:  Oxid Med Cell Longev       Date:  2012-04-26       Impact factor: 6.543

9.  The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders.

Authors:  Gerwyn Morris; Michael Berk
Journal:  BMC Med       Date:  2015-04-01       Impact factor: 8.775

Review 10.  Reappraisal of metabolic dysfunction in neurodegeneration: Focus on mitochondrial function and calcium signaling.

Authors:  Pooja Jadiya; Joanne F Garbincius; John W Elrod
Journal:  Acta Neuropathol Commun       Date:  2021-07-07       Impact factor: 7.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.